Drugs / MediHoney
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT04269694 | Mar → May 2020 | — | Riyadh Elm University | Unknown | No outcome recorded |
| Phase 4 | NCT03929224 | Oct 2018 → Sep 2020 | skin infection | Henry Ford Health System | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT02234479 | Jun → Nov 2014 | breast cancer, radiodermatitis | University of Maryland, Baltimore | Completed | No outcome recorded |
| — | NCT01230489 | Jan 2011 → Nov 2016 | kidney failure | University of Missouri-Columbia | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Medihoney | “comparing the effectiveness of a honey-based treatment (Medihoney) with that of the investigators current standard of care (Hydrophor)” NCT02234479 ↗ |
| Known as | Medicinal honey | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03929224 ↗ |
| Route | Topical | “Medicinal honey will be applied to the abutment site immediately after surgery” NCT03929224 ↗ |